Published in PLoS Pathog on March 14, 2013
New Structural Insights into the Genome and Minor Capsid Proteins of BK Polyomavirus using Cryo-Electron Microscopy. Structure (2016) 1.40
Structural Based Analyses of the JC Virus T-Antigen F258L Mutant Provides Evidence for DNA Dependent Conformational Changes in the C-Termini of Polyomavirus Origin Binding Domains. PLoS Pathog (2016) 1.40
Persistence and pathogenesis of the neurotropic polyomavirus JC. Ann Neurol (2015) 1.21
What is for dinner? Viral metagenomics of US store bought beef, pork, and chicken. Virology (2014) 1.08
Human polyomavirus 7-associated pruritic rash and viremia in transplant recipients. J Infect Dis (2014) 1.02
Host DNA damage response factors localize to merkel cell polyomavirus DNA replication sites to support efficient viral DNA replication. J Virol (2014) 0.96
Epigenetic regulation of polyomavirus JC. Virol J (2013) 0.95
Viruses and human cancers: a long road of discovery of molecular paradigms. Clin Microbiol Rev (2014) 0.93
The miRNA world of polyomaviruses. Virol J (2013) 0.82
Rad51 activates polyomavirus JC early transcription. PLoS One (2014) 0.81
Reactivation of human polyomaviruses in immunocompromised states. J Neurovirol (2014) 0.80
Downregulation of the stress-induced ligand ULBP1 following SV40 infection confers viral evasion from NK cell cytotoxicity. Oncotarget (2016) 0.79
Insights into the initiation of JC virus DNA replication derived from the crystal structure of the T-antigen origin binding domain. PLoS Pathog (2014) 0.78
Emerging Roles of Viroporins Encoded by DNA Viruses: Novel Targets for Antivirals? Viruses (2015) 0.78
Survey for human polyomaviruses in cancer. JCI Insight (2016) 0.78
A bacterial toxin and a nonenveloped virus hijack ER-to-cytosol membrane translocation pathways to cause disease. Crit Rev Biochem Mol Biol (2015) 0.77
Analysis of JC virus DNA replication using a quantitative and high-throughput assay. Virology (2014) 0.77
Diagnostic assays for polyomavirus JC and progressive multifocal leukoencephalopathy. Rev Med Virol (2015) 0.76
Identification of a polyomavirus microRNA highly expressed in tumors. Virology (2014) 0.76
How Polyomaviruses Exploit the ERAD Machinery to Cause Infection. Viruses (2016) 0.75
Emerging From the Unknown: Structural and Functional Features of Agnoprotein of Polyomaviruses. J Cell Physiol (2016) 0.75
Specific and quantitative detection of Human polyomaviruses BKPyV and JCPyV in the healthy Pakistani population. Virol J (2017) 0.75
In Vitro and In Vivo Models for the Study of Human Polyomavirus Infection. Viruses (2016) 0.75
Review on the role of the human Polyomavirus JC in the development of tumors. Infect Agent Cancer (2017) 0.75
The DNA damage response promotes polyomavirus JC infection by nucleus to cytoplasm NF- kappaB activation. Virol J (2017) 0.75
BK nephropathy in the native kidneys of patients with organ transplants: Clinical spectrum of BK infection. World J Transplant (2016) 0.75
p53 elevation in human cells halt SV40 infection by inhibiting T-ag expression. Oncotarget (2016) 0.75
Quantitative detection of human Malawi polyomavirus in nasopharyngeal aspirates, sera, and feces in Beijing, China, using real-time TaqMan-based PCR. Virol J (2017) 0.75
The genome of simian virus 40. Science (1978) 24.46
Complete nucleotide sequence of SV40 DNA. Nature (1978) 24.07
T antigen is bound to a host protein in SV40-transformed cells. Nature (1979) 17.78
Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science (2008) 16.60
New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet (1971) 12.13
Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet (1971) 11.92
The integrated state of viral DNA in SV40-transformed cells. Proc Natl Acad Sci U S A (1968) 8.38
Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog (2007) 8.01
Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med (2005) 7.54
The vacuolating virus, S.V. 40. Proc Soc Exp Biol Med (1960) 7.32
Identification of a third human polyomavirus. J Virol (2007) 7.06
Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med (2005) 7.04
Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med (2005) 6.33
Transformation induced by simian virus 40 in human renal cell cultures. I. Morphology and growth characteristics. Proc Natl Acad Sci U S A (1962) 5.15
Integrated simian virus 40 sequences in transformed cell DNA: analysis using restriction endonucleases. Proc Natl Acad Sci U S A (1976) 4.92
T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc Natl Acad Sci U S A (2008) 4.74
Seroepidemiology of human polyomaviruses. PLoS Pathog (2009) 4.62
Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. Cell Host Microbe (2010) 3.78
PARTICLES RESEMBLING PAPOVA VIRUSES IN HUMAN CEREBRAL DEMYELINATING DISEASE. Science (1965) 3.32
Neoplasms in mice inoculated with a tumor agent carried in tissue culture. J Natl Cancer Inst (1958) 3.28
Discovery of a new human polyomavirus associated with trichodysplasia spinulosa in an immunocompromized patient. PLoS Pathog (2010) 3.15
Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev (2012) 2.92
Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens. J Virol (2010) 2.88
Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer (2010) 2.68
Assignment of the T-antigen gene of simian virus 40 to human chromosome C-7. Proc Natl Acad Sci U S A (1973) 2.63
Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator. J Clin Invest (2011) 2.37
Reactivation and mutation of newly discovered WU, KI, and Merkel cell carcinoma polyomaviruses in immunosuppressed individuals. J Infect Dis (2009) 2.28
Identification of MW polyomavirus, a novel polyomavirus in human stool. J Virol (2012) 2.10
Taxonomical developments in the family Polyomaviridae. Arch Virol (2011) 2.03
A novel human polyomavirus closely related to the african green monkey-derived lymphotropic polyomavirus. J Virol (2011) 2.03
No evidence for an association between infections with WU and KI polyomaviruses and respiratory disease. J Clin Virol (2007) 1.96
Merkel cell carcinoma: critical review with guidelines for multidisciplinary management. Cancer (2007) 1.83
Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease. J Am Soc Nephrol (1999) 1.83
Detection of JC virus DNA fragments but not proteins in normal brain tissue. Ann Neurol (2008) 1.82
The decade of polyomavirus BK-associated nephropathy: state of affairs. Transplantation (2009) 1.81
Merkel cell carcinoma of the skin: pathological and molecular evidence for a causative role of MCV in oncogenesis. J Pathol (2009) 1.65
Regulation of gene expression in primate polyomaviruses. J Virol (2009) 1.61
Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy. J Virol (2006) 1.58
The polyomavirus, JCV and its involvement in human disease. Adv Exp Med Biol (2006) 1.55
Serologic evidence of frequent human infection with WU and KI polyomaviruses. Emerg Infect Dis (2009) 1.53
Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells. Proc Natl Acad Sci U S A (1990) 1.52
Persistent BK papovavirus infection of transformed human fetal brain cells. I. Episomal viral DNA in cloned lines deficient in T-antigen expression. J Virol (1979) 1.50
Electron microscopic observations on a case of progressive multifocal leukoencephalopathy. Acta Neuropathol (1965) 1.49
An intact retinoblastoma protein-binding site in Merkel cell polyomavirus large T antigen is required for promoting growth of Merkel cell carcinoma cells. Int J Cancer (2011) 1.49
Complete genome sequence of a tenth human polyomavirus. J Virol (2012) 1.48
Pathogenesis of progressive multifocal leukoencephalopathy--revisited. J Infect Dis (2011) 1.43
Merkel cell polyomavirus-specific CD8⁺ and CD4⁺ T-cell responses identified in Merkel cell carcinomas and blood. Clin Cancer Res (2011) 1.36
JC virus-induced changes in cellular gene expression in primary human astrocytes. J Virol (2003) 1.36
JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy. J Virol (2001) 1.35
Serological evidence of Merkel cell polyomavirus primary infections in childhood. J Clin Virol (2010) 1.34
Trichodysplasia spinulosa--a newly described folliculocentric viral infection in an immunocompromised host. J Investig Dermatol Symp Proc (1999) 1.33
JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy. J Virol (2009) 1.32
Reactivation of JC virus and development of PML in patients with multiple sclerosis. Neurology (2007) 1.32
Monoclonal antibodies and progressive multifocal leukoencephalopathy. MAbs (2010) 1.31
Merkel cell carcinoma: recent insights and new treatment options. Curr Opin Oncol (2012) 1.30
Seroepidemiology of the newly found trichodysplasia spinulosa-associated polyomavirus. J Infect Dis (2011) 1.28
Cross-reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides. J Virol (2005) 1.26
Seroprevalence of trichodysplasia spinulosa-associated polyomavirus. Emerg Infect Dis (2011) 1.25
Genome analysis of the new human polyomaviruses. Rev Med Virol (2012) 1.24
Detection of BK, JC, WU, or KI polyomaviruses in faecal, urine, blood, cerebrospinal fluid and respiratory samples. J Clin Virol (2009) 1.24
Cellular and viral factors regulating Merkel cell polyomavirus replication. PLoS One (2011) 1.21
Polyomaviruses and human cancer: molecular mechanisms underlying patterns of tumorigenesis. Virology (2004) 1.21
The agnoprotein of polyomaviruses: a multifunctional auxiliary protein. J Cell Physiol (2005) 1.21
Derivation and characterization of POJ cells, transformed human fetal glial cells that retain their permissivity for JC virus. J Virol (1987) 1.20
Carcinogenicity of malaria and of some polyomaviruses. Lancet Oncol (2012) 1.19
The novel KI, WU, MC polyomaviruses: possible human pathogens? New Microbiol (2011) 1.16
MCV and Merkel cell carcinoma: a molecular success story. Curr Opin Virol (2012) 1.14
Trichodysplasia spinulosa associated with chemotherapy for acute lymphocytic leukaemia. Australas J Dermatol (2007) 1.14
Progressive trichodysplasia spinulosa in a patient with chronic lymphocytic leukaemia in remission. Australas J Dermatol (2008) 1.12
Seroprevalence of human polyomavirus 9 and cross-reactivity to African green monkey-derived lymphotropic polyomavirus. J Gen Virol (2012) 1.12
Role for tumor necrosis factor-α in JC virus reactivation and progressive multifocal leukoencephalopathy. J Neuroimmunol (2010) 1.10
Transformation of human embryonic kidney cells by human papovarirus BK. J Virol (1979) 1.09
Persistent JC virus (JCV) infection is demonstrated by continuous shedding of the same JCV strains. J Clin Microbiol (1997) 1.07
Virus-associated trichodysplasia spinulosa. Am J Surg Pathol (2005) 1.07
Investigation of human brain tumors for the presence of polyomavirus genome sequences by two independent laboratories. Int J Cancer (2005) 1.05
Modulation of JC virus transcription by C/EBPbeta. Virus Res (2009) 1.05
Human polyomaviruses and brain tumors. Brain Res Brain Res Rev (2005) 1.04
Integration pattern of human JC virus sequences in two clones of a cell line established from a JC virus-induced hamster brain tumor. J Virol (1980) 1.03
Merkel cell polyomavirus large T antigen disrupts lysosome clustering by translocating human Vam6p from the cytoplasm to the nucleus. J Biol Chem (2011) 1.01
Seroprevalence and cross-reactivity of human polyomavirus 9. Emerg Infect Dis (2012) 1.00
NFAT4 is required for JC virus infection of glial cells. J Virol (2006) 0.99
Structural evaluation of new human polyomaviruses provides clues to pathobiology. Trends Microbiol (2010) 0.98
BK virus has tropism for human salivary gland cells in vitro: implications for transmission. Virology (2009) 0.98
Potential mechanisms of the human polyomavirus JC in neural oncogenesis. J Neuropathol Exp Neurol (2008) 0.98
Characterization of an early passage Merkel cell polyomavirus-positive Merkel cell carcinoma cell line, MS-1, and its growth in NOD scid gamma mice. J Virol Methods (2012) 0.96
Cooperative roles of NF-κB and NFAT4 in polyomavirus JC regulation at the KB control element. Virology (2012) 0.94
Owl monkey astrocytoma cells in culture spontaneously produce infectious JC virus which demonstrates altered biological properties. J Virol (1987) 0.93
Episomal DNA of a BK virus variant in a human insulinoma. J Med Virol (1983) 0.93
Human endothelial cells allow passage of an archetypal BK virus (BKV) strain--a tool for cultivation and functional studies of natural BKV strains. Arch Virol (2005) 0.92
BKV and JCV large T antigen-specific CD8+ T cell response in HLA A*0201+ kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy. J Clin Virol (2008) 0.90
Rare subtypes of BK virus are viable and frequently detected in renal transplant recipients with BK virus-associated nephropathy. Virology (2010) 0.89
T-helper cell-mediated proliferation and cytokine responses against recombinant Merkel cell polyomavirus-like particles. PLoS One (2011) 0.88
Polyomavirus JC infection inhibits differentiation of oligodendrocyte progenitor cells. J Neurosci Res (2012) 0.87
The arrangement of integrated viral DNA is different in BK virus-transformed mouse and hamster cells. Virology (1981) 0.86
Transcriptional regulation of BK virus by nuclear factor of activated T cells. J Virol (2009) 0.84
Prevalence of long-term BK and JC excretion in HIV-infected adults and lack of correlation with serological markers. J Med Virol (1999) 0.84
Polyoma-like virions in a human demyelinating disease. Acta Neuropathol (1967) 0.84
An siRNA against JC virus (JCV) agnoprotein inhibits JCV infection in JCV-producing cells inoculated in nude mice. Neuropathology (2007) 0.84
Dynamics of pregnancy-associated polyomavirus urinary excretion: a prospective longitudinal study. J Med Virol (2012) 0.83
Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation (2005) 3.57
Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev (2012) 2.92
Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol (2004) 2.20
An in vitro system for developmental and genetic studies of Leishmania donovani phosphoglycans. Mol Biochem Parasitol (2003) 2.07
Detection of JC virus DNA fragments but not proteins in normal brain tissue. Ann Neurol (2008) 1.82
Puralpha is essential for postnatal brain development and developmentally coupled cellular proliferation as revealed by genetic inactivation in the mouse. Mol Cell Biol (2003) 1.71
HIV-1 associated dementia: symptoms and causes. Retrovirology (2006) 1.70
Expression of human neurotropic polyomavirus JCV late gene product agnoprotein in human medulloblastoma. J Natl Cancer Inst (2002) 1.69
Cerebral hypoperfusion generates cortical watershed microinfarcts in Alzheimer disease. Stroke (2002) 1.66
Role of Pur alpha in targeting mRNA to sites of translation in hippocampal neuronal dendrites. J Neurosci Res (2006) 1.63
Regulation of gene expression in primate polyomaviruses. J Virol (2009) 1.61
Astrocyte-elevated gene-1 (AEG-1) induction by hypoxia and glucose deprivation in glioblastoma. Cancer Biol Ther (2011) 1.61
Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy. J Virol (2006) 1.58
The polyomavirus, JCV and its involvement in human disease. Adv Exp Med Biol (2006) 1.55
Association of human polyomavirus JCV with colon cancer: evidence for interaction of viral T-antigen and beta-catenin. Cancer Res (2002) 1.54
Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy. J Virol (2007) 1.52
Protective role of Puralpha to cisplatin. Cancer Biol Ther (2008) 1.44
Pathogenesis of progressive multifocal leukoencephalopathy--revisited. J Infect Dis (2011) 1.43
Development of a bidirectional caspase-3 expression system for the induction of apoptosis. Cancer Biol Ther (2008) 1.42
Role of Purα in the cellular response to ultraviolet-C radiation. Cell Cycle (2010) 1.41
Integrating role of T antigen, Rb2/p130, CTCF and BORIS in mediating non-canonical endoplasmic reticulum-dependent death pathways triggered by chronic ER stress in mouse medulloblastoma. Cell Cycle (2012) 1.41
Multiple roles for Puralpha in cellular and viral regulation. Cell Cycle (2009) 1.39
Human neurotropic polyomavirus, JCV, and its role in carcinogenesis. Oncogene (2003) 1.39
IKK{gamma} protein is a target of BAG3 regulatory activity in human tumor growth. Proc Natl Acad Sci U S A (2010) 1.36
JC virus-induced changes in cellular gene expression in primary human astrocytes. J Virol (2003) 1.36
Macrophage/microglial accumulation and proliferating cell nuclear antigen expression in the central nervous system in human immunodeficiency virus encephalopathy. Am J Pathol (2004) 1.28
BAG3 protein is overexpressed in human glioblastoma and is a potential target for therapy. Am J Pathol (2011) 1.27
CCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cells. FASEB J (2010) 1.23
Activation of the oxidative stress pathway by HIV-1 Vpr leads to induction of hypoxia-inducible factor 1alpha expression. J Biol Chem (2009) 1.21
Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells. Oncogene (2002) 1.21
Polyomaviruses and human cancer: molecular mechanisms underlying patterns of tumorigenesis. Virology (2004) 1.21
Persistence and pathogenesis of the neurotropic polyomavirus JC. Ann Neurol (2015) 1.21
Role of the insulin-like growth factor I/insulin receptor substrate 1 axis in Rad51 trafficking and DNA repair by homologous recombination. Mol Cell Biol (2003) 1.21
Evidence for BAG3 modulation of HIV-1 gene transcription. J Cell Physiol (2007) 1.20
Inhibition of SNAP25 expression by HIV-1 Tat involves the activity of mir-128a. J Cell Physiol (2008) 1.19
Evidence for dysregulation of cell cycle by human polyomavirus, JCV, late auxiliary protein. Oncogene (2002) 1.19
Functional interaction between JC virus late regulatory agnoprotein and cellular Y-box binding transcription factor, YB-1. J Virol (2002) 1.17
Insulin-like growth factor I receptor activity in human medulloblastomas. Clin Cancer Res (2002) 1.15
Detection of JC virus DNA sequences and expression of viral T antigen and agnoprotein in esophageal carcinoma. Cancer (2005) 1.15
Role of JC virus agnoprotein in DNA repair. J Virol (2004) 1.14
Progressive multifocal leukoencephalopathy: clinical and molecular aspects. Rev Med Virol (2011) 1.13
Primary central nervous system lymphoma expressing the human neurotropic polyomavirus, JC virus, genome. J Virol (2004) 1.13
Morphine treatment of human monocyte-derived macrophages induces differential miRNA and protein expression: impact on inflammation and oxidative stress in the central nervous system. J Cell Biochem (2010) 1.13
Tubulin-mediated binding of human immunodeficiency virus-1 Tat to the cytoskeleton causes proteasomal-dependent degradation of microtubule-associated protein 2 and neuronal damage. J Neurosci (2006) 1.12
Phosphorylation mutants of JC virus agnoprotein are unable to sustain the viral infection cycle. J Virol (2006) 1.12
Molecular mechanisms of necrosis in glioblastoma: the role of glutamate excitotoxicity. Cancer Biol Ther (2009) 1.10
Role for tumor necrosis factor-α in JC virus reactivation and progressive multifocal leukoencephalopathy. J Neuroimmunol (2010) 1.10
Alterations of DNA damage repair pathways resulting from JCV infection. Virology (2007) 1.10
Integrins mediate adhesion of medulloblastoma cells to tenascin and activate pathways associated with survival and proliferation. Lab Invest (2008) 1.10
Class III beta-tubulin is constitutively coexpressed with glial fibrillary acidic protein and nestin in midgestational human fetal astrocytes: implications for phenotypic identity. J Neuropathol Exp Neurol (2008) 1.09
Human polyomavirus JCV late leader peptide region contains important regulatory elements. Virology (2006) 1.09
T-antigen of the human polyomavirus JC attenuates faithful DNA repair by forcing nuclear interaction between IRS-1 and Rad51. J Cell Physiol (2006) 1.08
Expression of JC virus regulatory proteins in human cancer: potential mechanisms for tumourigenesis. Eur J Cancer (2005) 1.08
Effect of HIV-1 Vpr on cell cycle regulators. DNA Cell Biol (2004) 1.08
Activation of PPARalpha inhibits IGF-I-mediated growth and survival responses in medulloblastoma cell lines. Int J Cancer (2008) 1.08
Beta-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes. Neurobiol Aging (2006) 1.08
Cooperative interaction of C/EBP beta and Tat modulates MCP-1 gene transcription in astrocytes. J Neuroimmunol (2005) 1.07
Interplay between HIV-1 Vpr and Sp1 modulates p21(WAF1) gene expression in human astrocytes. J Biol Chem (2004) 1.07
JC virus encephalopathy is associated with a novel agnoprotein-deletion JCV variant. PLoS One (2012) 1.07
Impact of dermatologic adverse events on quality of life in 283 cancer patients: a questionnaire study in a dermatology referral clinic. Am J Clin Dermatol (2013) 1.06
Intracellular approach for blocking JC virus gene expression by using RNA interference during viral infection. J Virol (2004) 1.06
JC virus agnoprotein inhibits in vitro differentiation of oligodendrocytes and promotes apoptosis. J Virol (2007) 1.05
Interferon regulatory factor 7 is associated with Epstein-Barr virus-transformed central nervous system lymphoma and has oncogenic properties. J Virol (2004) 1.05
Modulation of JC virus transcription by C/EBPbeta. Virus Res (2009) 1.05
Early growth response-1 protein is induced by JC virus infection and binds and regulates the JC virus promoter. Virology (2008) 1.05
Human polyomaviruses and brain tumors. Brain Res Brain Res Rev (2005) 1.04
Regulation of MCP-1 gene transcription by Smads and HIV-1 Tat in human glial cells. Virology (2003) 1.03
Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes. Neurobiol Aging (2008) 1.03
Outcome of simian-human immunodeficiency virus strain 89.6p challenge following vaccination of rhesus macaques with human immunodeficiency virus Tat protein. J Virol (2002) 1.03
Interaction between JCV large T-antigen and beta-catenin. Oncogene (2004) 1.03
Dephosphorylation of JC virus agnoprotein by protein phosphatase 2A: inhibition by small t antigen. Virology (2008) 1.02
Effects of JC virus infection on anti-apoptotic protein survivin in progressive multifocal leukoencephalopathy. Am J Pathol (2007) 1.02
Cdk9 phosphorylates p53 on serine 392 independently of CKII. J Cell Physiol (2006) 1.02
JCV T-antigen interacts with the neurofibromatosis type 2 gene product in a transgenic mouse model of malignant peripheral nerve sheath tumors. Oncogene (2004) 1.01
HIV-1 Vpr modulates macrophage metabolic pathways: a SILAC-based quantitative analysis. PLoS One (2013) 1.01
Evidence for phosphatase activity of p27SJ and its impact on the cell cycle. J Cell Biochem (2009) 1.01
Analysis of a mutant p53 protein arising in a medulloblastoma from a mouse transgenic for the JC virus early region. Anticancer Res (2007) 1.01
Insulin receptor substrate 1 translocation to the nucleus by the human JC virus T-antigen. J Biol Chem (2002) 1.00
Viruses and cancer: lessons from the human polyomavirus, JCV. Oncogene (2003) 1.00
Regulation of human neurotropic JC virus replication by alternative splicing factor SF2/ASF in glial cells. PLoS One (2011) 0.99
Nuclear factor kappa B signaling initiates early differentiation of neural stem cells. Stem Cells (2012) 0.99
Borrelia burgdorferi persists in the brain in chronic lyme neuroborreliosis and may be associated with Alzheimer disease. J Alzheimers Dis (2004) 0.99
BAG3: a new player in the heart failure paradigm. Heart Fail Rev (2015) 0.98
MH2 domain of Smad3 reduces HIV-1 Tat-induction of cytokine secretion. J Neuroimmunol (2006) 0.98
Cooperativity between Rad51 and C/EBP family transcription factors modulates basal and Tat-induced activation of the HIV-1 LTR in astrocytes. J Cell Physiol (2006) 0.98
Potential mechanisms of the human polyomavirus JC in neural oncogenesis. J Neuropathol Exp Neurol (2008) 0.98